Depocyt and neurotoxicity Patient Reports February 13, 2012
Depocyt Side Effects Report #5725289-8
Depocyt side effect was reported by a Physician from NORWAY on Apr 11, 2008. Female patient, 53 years of age, was diagnosed with t-cell lymphoma and was treated with Depocyt. After drug was administered, patient experienced the following side effects: arachnoiditis, decerebration, disease progression, hyperaesthesia, neurotoxicity, posturing, pyrexia, somnolence. Depocyt dosage: 50 MG; 1X; INTH. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, METHOTREXATE, DESMOPRESSIN. Patient was hospitalized. Patient recovered.
Depocyt Side Effects Report #5023614-7
Depocyt side effect was reported by a Physician from GERMANY on May 23, 2006. Female patient, 47 years of age, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Depocyt. After drug was administered, patient experienced the following side effects: abasia, coordination abnormal, cystitis, gait disturbance, myelopathy, neurotoxicity, paralysis flaccid, paresis. Depocyt dosage: 50 MG; X1; INTH. During the same period patient was treated with METHOTREXATE, CYTARABINE, ADIURETINE, FRAGMIN. Patient was hospitalized and became disabled. Patient recovered.
Depocyt Side Effects Report #5613946-3
Depocyt side effect was reported by a Physician from GERMANY on Jan 21, 2008. Male patient, 61 years of age, weighting 191.8 lb, was diagnosed with metastases to meninges and was treated with Depocyt. After drug was administered, patient experienced the following side effects: fall
, gait disturbance, leukoencephalopathy, neurotoxicity. Depocyt dosage: 50 MG; QD; INTH. Patient recovered.Depocyt Side Effects Report #5794856-8
Depocyt side effect was reported by a Physician from GERMANY on June 16, 2008. Male patient, 42 years of age, was diagnosed with metastases to meninges and was treated with Depocyt. After drug was administered, patient experienced the following side effects: demyelination, dysarthria, fall
, foot fracture, gait disturbance, mental impairment, neurotoxicity, premature ageing. Depocyt dosage: 50 MG;QW;INTH. During the same period patient was treated with METHOTREXATE, IFOSFAMIDE. Patient recovered.Depocyt Side Effects Report #4615737-9
Depocyt side effect was reported by a Pharmacist from on Mar 04, 2005. Male patient, 56 years of age, was diagnosed with malignant nervous system neoplasm and was treated with Depocyt. After drug was administered, patient experienced the following side effects: confusional state, dysarthria, headache
, neurotoxicity. Depocyt dosage: 50 MG; EVERY OTHER WEEK; INTRATHECAL. During the same period patient was treated with CYTARABINE. Patient recovered.Depocyt Side Effects Report #5804290-X
Depocyt side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 26, 2008. Female patient, 33 years of age, was diagnosed with lymphoma
and was treated with Depocyt. After drug was administered, patient experienced the following side effects: ataxia
, balance disorder, central nervous system inflammation, disease progression, headache
, intracranial pressure increased, neurotoxicity, papilloedema, visual impairment. Depocyt dosage: 50 MG; INTH. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE. Patient recovered.Depocyt Side Effects Report #5582801-X
Depocyt side effect was reported by a Physician from POLAND on Dec 17, 2007. Male patient, weighting 154.3 lb, was diagnosed with lymphoma
and was treated with Depocyt. After drug was administered, patient experienced the following side effects: circulatory collapse, hypotonia, neurotoxicity, paresis, quadriplegia, spinal shock. Depocyt dosage: 50 MG;QD;INTH. During the same period patient was treated with DAUNORUBICIN, ONCASPAR, CYCLOPHOSPHAMIDE, CYTOSINE ARABINOSIDE. Patient was hospitalized and became disabled. Patient recovered.Depocyt Side Effects Report #4781561-X
Depocyt side effect was reported by a Health Professional from UNITED KINGDOM on Sept 05, 2005. Female patient was diagnosed with lymphoma
and was treated with Depocyt. After drug was administered, patient experienced the following side effects: cerebrovascular accident, facial palsy, neurotoxicity, paraesthesia, paralysis
. Depocyt dosage: unknown. During the same period patient was treated with METHOTREXATE, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.Depocyt Side Effects Report #5635689-2
Depocyt side effect was reported by a Consumer or non-health professional from AUSTRIA on Feb 06, 2008. Female patient, 75 years of age, weighting 150.6 lb, was diagnosed with leukaemic infiltration brain and was treated with Depocyt. After drug was administered, patient experienced the following side effects: conus medullaris syndrome, neurotoxicity. Depocyt dosage: 50 MG;QOM;INTH. Patient was hospitalized and became disabled. Patient recovered.
Depocyt Side Effects Report #4982803-8
Depocyt side effect was reported by a Physician from UNITED STATES on Apr 07, 2006. Female patient, 18 years of age, was diagnosed with leukaemia recurrent prophylaxis and was treated with Depocyt. After drug was administered, patient experienced the following side effects: headache
, intracranial pressure increased, neurotoxicity, obstruction, papilloedema, subdural haematoma, vision blurred. Depocyt dosage: 50 MG;QOW;INTH. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, CYTARABINE, VINCRISTINE, NEUPOGEN, CIPROFLOXACIN, CANCIDAS, VALTREX. Patient was hospitalized and became disabled. Patient recovered.Depocyt Side Effects Report #4969549-7
Depocyt side effect was reported by a Physician from UNITED STATES on Mar 24, 2006. Male patient, 59 years of age, was diagnosed with leukaemia, prophylaxis and was treated with Depocyt. After drug was administered, patient experienced the following side effects: anaemia, enterococcal infection, febrile neutropenia, lung infiltration, neurotoxicity. Depocyt dosage: 50 MG; INTH. During the same period patient was treated with VANCOMYCIN, MERREM, DIFLUCAN, VALTREX, FLAGYL, HYPER, BLOOD TRANSFUSION. Patient was hospitalized. Patient recovered.
Depocyt Side Effects Report #5261421-0
Depocyt side effect was reported by a Physician from SPAIN on Feb 23, 2007. Male patient, 57 years of age, weighting 169.8 lb, was diagnosed with leukaemia and was treated with Depocyt. After drug was administered, patient experienced the following side effects: diplopia, dysphonia, febrile neutropenia, headache
, monoplegia, neurotoxicity. Depocyt dosage: 50 MG;QOW; INTH. Patient was hospitalized. Patient recovered.Depocyt Side Effects Report #5824610-X
Depocyt side effect was reported by a Physician from FRANCE on July 07, 2008. Male patient, 21 years of age, was diagnosed with leukaemia and was treated with Depocyt. After drug was administered, patient experienced the following side effects: facial palsy, neurotoxicity, puncture site haemorrhage. Depocyt dosage: 50 MG/QOW;INTH. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Depocyt Side Effects Report #5538459-9
Depocyt side effect was reported by a Physician from FRANCE on Nov 20, 2007. Female patient, 65 years of age, was diagnosed with central nervous system lymphoma and was treated with Depocyt. After drug was administered, patient experienced the following side effects: cauda equina syndrome, neurotoxicity. Depocyt dosage: 50 MG;X4. Patient was hospitalized. Patient recovered.
Depocyt Side Effects Report #5671581-5
Depocyt side effect was reported by a Physician from FRANCE on Feb 28, 2008. Female patient, 64 years of age, was diagnosed with central nervous system lymphoma and was treated with Depocyt. After drug was administered, patient experienced the following side effects: cauda equina syndrome, disease progression, faecal incontinence, inflammation, mobility decreased, neurotoxicity, procedural complication, urinary incontinence
. Depocyt dosage: 50 MG;X4;. During the same period patient was treated with MABTHERA, CHLORAMINOPHEN, CORTANCYL, TAHOR, AMILORIDE HYDROCHLORIDE, ALPRESS, MODOPAR. Patient was hospitalized. Patient recovered.Depocyt Side Effects Report #5798678-3
Depocyt side effect was reported by a Physician from FINLAND on June 11, 2008. Female patient, 64 years of age, was diagnosed with central nervous system lymphoma and was treated with Depocyt. After drug was administered, patient experienced the following side effects: depressed level of consciousness, dyspnoea, neurotoxicity, pyrexia. Depocyt dosage: 50 MG;1X;INH. During the same period patient was treated with IFOSFAMIDE, DEXAMETHASONE, METHOTREXATE. Patient recovered.
Depocyt Side Effects Report #5844616-4
Depocyt side effect was reported by a Physician from FINLAND on July 28, 2008. Female patient, 64 years of age, was diagnosed with central nervous system lymphoma and was treated with Depocyt. After drug was administered, patient experienced the following side effects: coma, depressed level of consciousness, disease progression, dyspnoea, neurotoxicity, pyrexia. Depocyt dosage: 50 MG; 1X; INTH. During the same period patient was treated with IFOSFAMIDE, HOLOXAN, DEXAMETHASONE, METHOTREXATE. Patient recovered.
Depocyt Side Effects Report #6107482-8
Depocyt side effect was reported by a Physician from GERMANY on Feb 20, 2009. Female patient, 50 years of age, was diagnosed with central nervous system leukaemia and was treated with Depocyt. After drug was administered, patient experienced the following side effects: neurotoxicity, paraesthesia, peroneal nerve palsy, polyneuropathy. Depocyt dosage: 40 MG; X2; INTH. Patient recovered.
Depocyt Side Effects Report #5386085-7
Depocyt side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 25, 2007. Male patient, 23 years of age, weighting 172.0 lb, was diagnosed with burkitt's lymphoma and was treated with Depocyt. After drug was administered, patient experienced the following side effects: diplopia, epilepsy
, neurotoxicity, pancytopenia, papilloedema, vision blurred, vith nerve paralysis. Depocyt dosage: 50 MG;X2;INTH. During the same period patient was treated with METHOTREXATE, SENDOXAN, HOLOXAN, ONCOVIN, DECADRON, RITUXAN, DOXORUBICIN. Patient recovered.Depocyt Side Effects Report #5009718-3
Depocyt side effect was reported by a Physician from UNITED STATES on May 09, 2006. Female patient was diagnosed with breast cancer
, metastases to central nervous system and was treated with Depocyt. After drug was administered, patient experienced the following side effects: balance disorder, feeling abnormal, gait disturbance, headache
, muscular weakness, nausea
, neuropathy peripheral, neurotoxicity, pain
. Depocyt dosage: 50 MG;XL; INTH. During the same period patient was treated with DECADRON SRC, HERCEPTIN, NAVELBINE, METHOTREXATE, ZOFRAN, COUMADIN. Patient was hospitalized. Patient recovered.Depocyt Side Effects Report #5291404-6
Depocyt side effect was reported by a Physician from GERMANY on Mar 15, 2007. Female patient, 53 years of age, was diagnosed with acute lymphocytic leukaemia recurrent and was treated with Depocyt. After drug was administered, patient experienced the following side effects: brain oedema, dizziness
, muscular weakness, neurotoxicity, proctalgia, progressive multifocal leukoencephalopathy. Depocyt dosage: 50 MG; INTH. During the same period patient was treated with TORSEMIDE, LYRICA, GANCICLOVIR, DASATINIB. Patient was hospitalized. Patient recovered.Depocyt Side Effects Report #5804289-3
Depocyt side effect was reported by a Physician from BELGIUM on June 27, 2008. Female patient, 77 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Depocyt. After drug was administered, patient experienced the following side effects: arachnoiditis, central nervous system leukaemia, colitis, disease progression, encephalopathy, neurotoxicity, overdose, pain
. Depocyt dosage: 50 MG, QOW; INTH. During the same period patient was treated with METHOTREXATE, DEXAMETHASONE, GLAZIDIM, LORAZEPAM, CITALOPRAM HYDROBROMIDE, ZANTAC, METFORMIN, CETIRIZINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Depocyt and neurotoxicity 